Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact
Login Book a demo
Stellaromics Inc. logo — Helping the world see biology, in all dimensions.

Stellaromics Inc.

Helping the world see biology, in all dimensions.

Founded 2022 United States Boston, United States 57 employees Series B Total: $105.00M Biotechnology, VR/AR

General Information

Company Name Stellaromics Inc.
Founded Year 2022
Location United States Boston, United States
Employees 57
Industries Biotechnology, VR/AR
Funding Stage Series B
Social

BounceWatch is an independent company data service, not affiliated with Stellaromics Inc.. To contact Stellaromics Inc., visit stellaromics.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Stellaromics Inc. compare?

A PDF of Stellaromics Inc. and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Stellaromics Inc. soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

Recorded by Bounce Watch from public sources. Every entry below carries the date we observed it, and when we have not looked recently the page says so rather than leaving silence to imply nothing happened.

Product Launch Sep 28, 2026

Stellaromics Inc. is showcasing its Pyxa platform, described as the "only platform for true 3D spatial multi-omics," to uncover biological insights.

Get alerts when Stellaromics Inc. shows new signals

About Stellaromics Inc.

Stellaromics Inc. is a revolutionary biotechnology startup, established in 2022 and based in Boston, United States. The company's mission is encapsulated in its slogan, "Achieve your next breakthrough using the world’s most powerful 3D in situ multi-omic analysis technology." At the core of Stellaromics' innovation is its proprietary technology, which focuses on deciphering intricate 3D transcription and translation patterns within native biological tissue. Their leading product, STARmap (Spatially-resolved Transcript Amplicon Readout mapping), enables researchers to uncover gene expression patterns within intact tissue, aiding in the identification of treatment targets and enhancing biomedical investigations. Moreover, Stellaromics is in the advanced stages of developing Plexa™, a suite of products tailored to empower researchers and clinicians in the creation of comprehensive cellular maps. This initiative is poised to enhance our understanding of various diseases. The company secured a significant $25.00M Series A investment on 02 November 2023, with Plaisance Capital Management as the investor. Stellaromics' innovative approach in biotechnology has the potential to reshape the landscape of biomedical research, offering unique solutions for unraveling complex biological processes. For further insights, refer to their website at stellaromics.com. This signifies an opportunity for investors to participate in shaping the future of biomedical research.

Business keywords: 3D in situ multi-omic analysis, biomedical research, transcription analysis, translation analysis, native biological tissue, STARmap, Plexa suite, cellular maps, disease comprehension, spatial transcriptomics, genomics, functional genomics, RNA therapeutics, small RNA detection

Funding Rounds & Investors (3)

View All
Funding Stage Amount Investors Lead Investors Date
Series B $80.00M 2
Catalyst4, Stanford Technology Ventures Program
01 Feb 2025
Series A $25.00M 1
Plaisance Capital Management LLC
Plaisance Capital Management LLC
01 Nov 2023
Spinout Undisclosed 2
Broad Institute, Stanford University
01 Jan 2022

FAQ About Stellaromics Inc.

Helping the world see biology, in all dimensions.
Stellaromics Inc. was founded in 2022.
Stellaromics Inc. is headquartered in Boston, United States.
Stellaromics Inc. operates in Biotechnology and VR/AR. Its work centres on 3D in situ multi-omic analysis, biomedical research, transcription analysis and translation analysis.
Stellaromics Inc. has approximately 57 employees.
Stellaromics Inc. has completed 3 funding rounds, raising a total of $105.00M. The latest funding stage is Series B.

We're actively collecting intelligence on Stellaromics Inc..

Source: BounceWatch company record for Stellaromics Inc., https://bouncewatch.com/company/stellaromics-inc, updated 30 June 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes